Advertisement

Topics

Aptima, Inc. Company Profile

14:33 EST 17th November 2017 | BioPortfolio

Aptima specializes in solving the problems of human performance in today’s complex sociotechnical systems . We are market leaders in the design of organizations, user-centered technology and training systems that make individuals and teams more effective. Aptima’s unique approach – human-centered engineering – couples the principles of social science with quantitative, computational methods. We have a ten-year track record of success in delivering quantifiable performance improvements at all levels of commercial, government and military organizations.By using its expertise in how humans operate in complex environments, Aptima also provides modeling and decision support for counter-terrorism and intelligence activities.

Location

12 Gill Street, Suite 1400
Woburn
Massachusetts
01801
United States of America

Contact

Phone: 781.935.3966
Fax: 781.935.4385
Email: aptima_info@aptima.com.


News Articles [4 Associated News Articles listed on BioPortfolio]

Hologic wins FDA approval for Aptima HSV 1 & 2 molecular assay

Medical technology firm Hologic has secured approval from the US Food and Drug Administration (FDA) for its Aptima assay for the detection of herpes simplex virus (HSV) 1 & 2.

FDA approves Hologic's Aptima HSV 1 & 2 assay

FDA clears Hologic's HSV assay on Panther system

The FDA has given 510(k) clearance to Hologic for its Aptima Herpes Simplex Virus 1 & 2 molecular assay as part of its fully  -More- 

New Aptima Mycoplasma genitalium Assay Evaluated

Mycoplasma genitalium (MG) frequently causes non-gonococcal urethritis (NGU) in males, and is associated with cervicitis, pelvic inflammatory disease, endometritis and...

Drugs and Medications [0 Results]

None

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Performance evaluation of the Aptima(®) HCV Quant Dx assay for hepatitis C virus (HCV) RNA detection and quantification in comparison to the Abbott RealTime HCV assay.

The Aptima HCV Quant Dx assay (Aptima) is a real-time transcription-mediated amplification assay CE-approved for the diagnosis and monitoring of hepatitis C virus (HCV) infection.

The New Aptima HCV Quant Dx Real-time TMA Assay Accurately Quantifies Hepatitis C Virus Genotype 1-6 RNA.

Sensitive and accurate hepatitis C virus (HCV) RNA detection and quantification is essential for the management of chronic hepatitis C therapy. Currently available platforms and assays are usually bat...

Comparison of the Hologic Aptima HIV-1 Quant Dx Assay to the Roche COBAS Ampliprep/COBAS TaqMan HIV-1 Test v2.0 for the quantification of HIV-1 RNA in plasma samples.

HIV-RNA is the most important parameter for monitoring antiviral treatment in individuals infected with HIV-1. Knowledge of the performance of different tests for the quantification of HIV-1 RNA is th...

Audit of Trichomonas vaginalis test requesting by community referrers after a change from culture to molecular testing, including a cost analysis.

Trichomonas vaginalis (TV) prevalence varies among different communities and peoples. The availability of robust molecular platforms for the detection of TV has advanced diagnosis; however, molecular ...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Collection of Samples From HIV-1 Infected Individuals for Evaluation of the Aptima HIV-1 Assay

The objective is to obtain plasma samples from Human Immunodeficiency Virus Type 1 (HIV-1) infected individuals that have viral loads across the dynamic range of the Aptima HIV-1 assay. Th...

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

To assess and compare the performance of the HR HPV HC2® test (Qiagen/Digene) and the APTIMA® HPV Assay (Hologic) using LBC Specimens (ThinPrep® Pap Test) for the detection of HPV infec...

Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

This non-interventional clinical study will be conducted to prospectively collect serial plasma samples from subjects with chronic HBV infection who are initiating antiviral therapy. These...

Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples

The objective of this study is to evaluate the performance characteristics of the AC2 assay on the Panther system using female urine specimens.

Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing

This non-interventional clinical study will be conducted to prospectively collect serial plasma and serum samples from treatment naïve subjects with chronic HCV infection who are initiati...

Companies [2 Associated Companies listed on BioPortfolio]

Aptima, Inc.

Aptima specializes in solving the problems of human performance in today’s complex sociotechnical systems . We are market leaders in the design of organizations, user-centered technology and trainin...

Gen-Probe Life Sciences Ltd

Gen-Probe Incorporated (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) used primarily to diagnose human ...

More Information about "Aptima, Inc." on BioPortfolio

We have published hundreds of Aptima, Inc. news stories on BioPortfolio along with dozens of Aptima, Inc. Clinical Trials and PubMed Articles about Aptima, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Aptima, Inc. Companies in our database. You can also find out about relevant Aptima, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record